Histology
Basal Cell Carcinoma
CI-CAN-00000479Explore in graph →
57 active trials4 approved drugs6 evidence items
Loading cancer entity…
Loading cancer entity…
Histology
CI-CAN-00000479Explore in graph →
Clinical trials
361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (25)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05234658 | Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery | unknown | Phase 2 | 21 | Andalusian Network for Design and Translation of Advanced TherapiesOTHER | 1 | Nov 8, 2023 | clinicaltrials |
| NCT04362722 | Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients(DUNCAN) | unknown | Phase 2 | 40 | Philogen S.p.A.INDUSTRY | 3 | Oct 10, 2023 |
| clinicaltrials |
| NCT00314756 | Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage | completed | Phase 4 | 15 | Wake Forest UniversityOTHER | 1 | Aug 22, 2023 | clinicaltrials |
| NCT04688749 | Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage(DermaSense) | terminated | — | 50 | Aristotle University Of ThessalonikiOTHER | 1 | Jul 25, 2023 | clinicaltrials |
| NCT05247710 | Differential Mobility Spectrometry (DMS) Based Skin Tumor Analysis | unknown | — | 40 | Tampere University HospitalOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05126173 | DERM US and EU Validation Study | completed | — | 1,111 | Skin Analytics LimitedINDUSTRY | 2 | Jun 28, 2023 | clinicaltrials |
| NCT05898347 | Nevoid Basal Cell Carcinomas in Gorlin Syndrome | unknown | — | 10 | Oslo University HospitalOTHER | 1 | Jun 12, 2023 | clinicaltrials |
| NCT03982212 | A Window of Opportunity Trial of Intratumoral Injection of Copaxone® in Patients With Percutaneously Accessible Tumors | unknown | Phase 1 | 10 | University of Kansas Medical CenterOTHER | 1 | May 19, 2023 | clinicaltrials |
| NCT05853315 | BCC Excision Revisited | completed | — | 451 | Medical University of ViennaOTHER | 1 | May 16, 2023 | clinicaltrials |
| NCT04928222 | Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) | active not recruiting | Phase 1 / Phase 2 | 25 | SkinJect, Inc.INDUSTRY | 1 | Apr 14, 2023 | clinicaltrials |
| NCT03769285 | Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial(SPRINTR-Pilot) | unknown | Phase 2 | 120 | Women's College HospitalOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05170035 | Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery | unknown | N/A | 26 | Bispebjerg HospitalOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT05698706 | High Intensity Focused Ultrasound (HIFU) Treatment of Basal Cell Carcinoma(HIFU-BCC) | unknown | N/A | 27 | Jacek CalikOTHER | 1 | Feb 2, 2023 | clinicaltrials |
| NCT04918381 | CellFX Treat & Resect Low-Risk BCC Feasibility Study | completed | N/A | 30 | Pulse Biosciences, Inc.INDUSTRY | 1 | Jan 11, 2023 | clinicaltrials |
| NCT00473343 | Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma | completed | Phase 3 | 102 | Galderma R&DINDUSTRY | 1 | Jan 5, 2023 | clinicaltrials |
| NCT03775525 | Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer(GEN602) | unknown | Phase 1 | 127 | Genzada Pharmaceuticals USA, Inc.INDUSTRY | 1 | Dec 23, 2022 | clinicaltrials |
| NCT01016899 | Electronic Brachytherapy for the Treatment of NMSC | completed | — | 187 | Xoft, Inc.INDUSTRY | 1 | Dec 13, 2022 | clinicaltrials |
| NCT04936932 | Laser Treatment of Basal Cell Carcinoma | completed | N/A | 3 | ScitonINDUSTRY | 1 | Dec 8, 2022 | clinicaltrials |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors(DUET-2) | completed | Phase 1 | 150 | Xencor, Inc.INDUSTRY | 1 | Dec 1, 2022 | clinicaltrials |
| NCT05628714 | A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma | completed | — | 222 | Maastricht University Medical CenterOTHER | 1 | Nov 29, 2022 | clinicaltrials |
| NCT02144077 | Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy | completed | Phase 3 | 281 | Biofrontera Bioscience GmbHINDUSTRY | 1 | Nov 3, 2022 | clinicaltrials |
| NCT00540566 | Optical Biopsy of Human Skin in Conjunction With Laser Treatment | completed | — | 113 | University of California, IrvineOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05581342 | Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment(TOBI) | completed | N/A | 100 | Maastricht University Medical CenterOTHER | 1 | Oct 14, 2022 | clinicaltrials |
| NCT04929535 | Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment | unknown | Phase 2 | 51 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Aug 30, 2022 | clinicaltrials |
| NCT00470496 | Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer | completed | Phase 1 | 15 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT05402046 | Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms(CAMELLIA) | unknown | N/A | 605 | MelanomaPRO, RussiaOTHER | 1 | Jun 2, 2022 | clinicaltrials |
| NCT05340543 | Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)(DERMOCTAV) | unknown | — | 150 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT03541252 | Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study | completed | Phase 1 / Phase 2 | 20 | Merete HaedersdalOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT05324202 | New Imaging Procedures and Therapeutic Approach in Basal Cell Carcinoma Management | unknown | N/A | 50 | Dr. Stephanie GeislerOTHER | 0 | Apr 12, 2022 | clinicaltrials |
| NCT03458117 | T-VEC in Non-melanoma Skin Cancer(20139157 T-VEC) | completed | Phase 1 | 26 | University of ZurichOTHER | 1 | Mar 18, 2022 | clinicaltrials |
| NCT00189280 | Aldara for the Treatment of Large and/or Multiple sBCC | completed | Phase 3 | 111 | MEDA Pharma GmbH & Co. KGINDUSTRY | 1 | Feb 22, 2022 | clinicaltrials |
| NCT03035188 | Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma(NICCI) | completed | Phase 2 | 40 | SRH Wald-Klinikum Gera GmbHOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT00189241 | A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma | completed | Phase 3 | 160 | MEDA Pharma GmbH & Co. KGINDUSTRY | 1 | Feb 7, 2022 | clinicaltrials |
| NCT05157763 | A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma | recruiting | Phase 1 / Phase 2 | 32 | MediWound LtdINDUSTRY | 1 | Dec 15, 2021 | clinicaltrials |
| NCT00793169 | Serum Concentration of Lidocaine After Local Injection During Mohs Micrographic Surgery | completed | — | 19 | Northwestern UniversityOTHER | 1 | Dec 6, 2021 | clinicaltrials |
| NCT00882791 | Basal Cell Carcinoma Recurrence After Mohs Surgery | completed | — | 115 | Northwestern UniversityOTHER | 1 | Dec 2, 2021 | clinicaltrials |
| NCT04279535 | Topical Vitamin C for Treatment of Basal Cell Cancer | completed | Early Phase 1 | 25 | Center for Biomedical Research, Inc.INDUSTRY | 1 | Nov 2, 2021 | clinicaltrials |
| NCT02436408 | VISmodegib for ORbital and Periocular Basal Cell Carcinoma(VISORB) | completed | Phase 4 | 35 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT02242929 | Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma(SCIN) | unknown | Phase 3 | 145 | Maastricht University Medical CenterOTHER | 1 | Sep 24, 2021 | clinicaltrials |
| NCT05046262 | Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study | unknown | Phase 3 | 25 | Bispebjerg HospitalOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT05041777 | Optical-Coherence Tomography for the Non-invasive Diagnosis and Subtyping of Basal Cell Carcinoma(OCT-BCC) | unknown | — | 963 | Maastricht University Medical CenterOTHER | 1 | Sep 13, 2021 | clinicaltrials |
| NCT03167762 | Photographing the Skin During Photodynamic Therapy | completed | N/A | 18 | University of DundeeOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04093401 | The VIDYA Study-designed to Determine if Patients With a History of Basal Cell Carcinoma Are More Inclined to Return for Follow-up if Their Risk of a Subsequent Basal Cell Carcinoma is Quantitated. | withdrawn | N/A | 0 | University of Wisconsin, MadisonOTHER | 0 | Jul 14, 2021 | clinicaltrials |
| NCT00847912 | CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial(VAKCCT) | completed | Phase 4 | 954 | VA Office of Research and DevelopmentFED | 1 | Jun 11, 2021 | clinicaltrials |
| NCT03180528 | Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer | completed | Phase 2 | 30 | Kavita SarinOTHER | 1 | Jun 8, 2021 | clinicaltrials |
| NCT02781389 | Vismodegib on Locally Advanced Basal Cell Carcinoma Under Real World Conditions(JONAS) | completed | — | 53 | University Hospital, EssenOTHER | 1 | Jun 3, 2021 | clinicaltrials |
| NCT01835626 | Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma | completed | Phase 2 | 24 | Sue YomOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT04795297 | Observational Study of Correlation Between Recurrent Basal Cell Carcinoma and Localisation | completed | — | 804 | University Hospital, MontpellierOTHER | 1 | Mar 12, 2021 | clinicaltrials |
| NCT03848078 | (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC)(ROCTI) | unknown | N/A | 598 | Maastricht University Medical CenterOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT03742726 | Study Assessing the Safety and Performance of Smart Matrix® | unknown | N/A | 32 | Smart Matrix LimitedOTHER | 1 | Feb 21, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Nov 8, 2023source: clinicaltrials